Gene Expressions and High Lymphocyte Count May Predict Durable Clinical Benefits in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

por Mouritzen, Mette T., Ladekarl, Morten, Hager, Henrik, Mattesen, Trine B., Lippert, Julie B., Frank, Malene S., Nøhr, Anne K., Egendal, Ida B., Carus, Andreas
Publicado 2023

A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)

por Rasmussen, Louise Skau, Winther, Stine B., Chen, Inna M., Weber, Britta, Ventzel, Lise, Liposits, Gabor, Johansen, Julia Sidenius, Detlefsen, Sönke, Egendal, Ida, Shim, Susy, Christensen, Signe, Pfeiffer, Per, Ladekarl, Morten
Publicado 2023